logo
episode-header-image
Jul 2022
29m 14s

FT Weekend: A new weight-loss drug works...

Financial Times
About this episode
tail spinning
Up next
Today
Martin Wolf on the US midterms: Trump loses. European populism lives on.
Before the 2026 midterms, Timothy Garton Ash, emeritus professor of European studies at the University of Oxford and author of ‘Europe in 7½ Chapters’, described the elections as a crucial test of US democracy. Now, with the Democrats’ sweeping victory, could the tide be turning ... Show More
40m 51s
Yesterday
Nvidia after Jensen Huang
Jensen Huang has resigned as Nvidia CEO. We look at what it means for the company, AI sector, stock market and the US government’s relationship with China. Plus, European leaders reject Vladimir Putin’s push to overhaul the continent’s security architecture as part of Ukraine pea ... Show More
14m 34s
Nov 12
Nvidia board meets to discuss Huang’s future
Nvidia’s board is holding urgent talks about the future of its founder Jensen Huang after revelations that he had an affair with a top executive at the company. European leaders meet in Dublin today to reheat an interminable debate over how to speak to Russia. Plus, Spain’s first ... Show More
11m 27s
Recommended Episodes
Jul 2023
One Thing: Weight Loss Drugs: Trend or Treatment?
A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ... Show More
17m 14s
Dec 2024
A checkup on weight-loss drugs
What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ... Show More
20m 17s
Apr 2023
Those New Obesity Drugs Really Work–If You Can Afford Them
Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ... Show More
25m 18s
May 2024
Ozempic: Magic Pill or Devil’s Bargain?
Ozempic has fast become the buzzword for dramatic weight loss, and considering the results users have been reporting, it’s easy to see why. To discuss the supposed miracle drug, Piers Morgan has assembled an all-star panel of doctors and patients, including; Journalist and author ... Show More
45m 22s
Jan 2024
Is Ozempic Really A Miracle Drug?
New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay Gupta turns to Yale School of Medicine assistant professor Dr. Jorge Moreno to explain the science behind these medications – ... Show More
30m 13s
Dec 2024
068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ... Show More
11m 16s
Dec 2023
The Weight-Loss Drug Revolution, Part 1: Why These Drugs Work So Well
Today’s podcast is about the weight-loss drug revolution—which I believe might be one of the most important stories in the world right now. Despite all the attention weight-loss drugs are receiving, it’s possible that they might soon affect the world even more than we realize as ... Show More
50m 34s